跳至主要内容
临床试验/NCT00766207
NCT00766207已完成不适用

Preconception Risk Evaluation Via Electronic Medical Record Notification of Teratogenic Risks

University of Pittsburgh4 个研究点 分布在 1 个国家目标入组 2,593 人开始时间: 2008年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
2,593
试验地点
4
主要终点
Proportion of women prescribed potentially teratogenic medications with documented use of contraception

研究概览

简要总结

This study will use a factorial design randomized controlled trial to (1)compare multi-faceted decision support (intervention) to streamlined clinical alerts (control) and (2) evaluate whether collecting information about women's risk of pregnancy using a networked tablet computer (intervention) is superior to the way clinicians usually collect this information (control).

Over the course of 1 year, we will abstract data from the electronic medical record when study clinicians prescribe teratogenic medications, conduct phone interviews with women prescribed medications by participating clinicians, and survey participating clinicians about their satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction with the counseling they received, and (4) report more satisfaction with the decision support they received.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Women aged 18-45 seen at a participating primary care clinic

排除标准

  • •Non-English speakers

研究组 & 干预措施

multi-faceted decision support

Experimental

Multi-faceted decision support

干预措施: Clinical decision support (Other)

control

Active Comparator

stream-lined clinical alert

干预措施: stream-lined clinical alert (Other)

结局指标

主要结局

Proportion of women prescribed potentially teratogenic medications with documented use of contraception

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (4)

Loading locations...

相似试验